Long term treatment by carmustine, a chemical relative of mustard gas and already used to treat some types of brain cancer, can decrease the amount of amyloid β and number of amyloid plaques in a mouse model of Alzheimer's ...
Mar 25, 2013
0
0
Findings from a Loyola University Chicago Stritch School of Medicine study could lead to the development of new drugs to treat gout. The study, led by Liang Qiao, MD, and his colleagues and collaborators, was published March ...
Mar 19, 2013
0
0
The liver is an important target organ for drug testing because all drugs pass through it for detoxification. This is a process whereby harmful substances are reduced or removed from the body. Drugs that cannot be detoxified ...
Mar 15, 2013
0
0
Sunny with a chance of flu? That's what some health scientists are thinking, as they study the weather for clues about how to predict disease outbreaks.
Jan 3, 2013
0
0
Global travel and climate warming could be creating the right conditions for outbreaks of a new virus in this country, according to a new Cornell University computer model.
Dec 17, 2012
0
0
(Medical Xpress)—Researchers at the University of Virginia have developed a new model of how the heart reacts to stresses such as high blood pressure, shedding light on a common cause of heart failure and facilitating the ...
Dec 13, 2012
0
0
Recent research has shown that there are new cells that develop in the heart, but how these cardiac cells are born and how frequently they are generated remains unclear. In new research from Brigham and Women's Hospital (BWH), ...
Dec 5, 2012
0
0
Deliberately inflicting carefully controlled painful stimuli on human volunteers and seeing how well specific drugs reduce the feeling of pain can be an effective way of testing new drugs. So conclude two researchers who ...
Nov 8, 2012
0
0
There is an urgent need for new drugs to treat Rett syndrome, a rare and severe neurological disease mainly affecting girls. A bottleneck in drug development for this syndrome is a lack of clarity at the level of preclinical ...
Oct 31, 2012
0
0
They say the real crisis stems from current incentives that reward companies for developing large numbers of new drugs with few clinical advantages over existing ones.
Aug 7, 2012
0
0
